Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Cytomegalovirus Infection

  Free Subscription


Articles published in Transplant Proc

Retrieve available abstracts of 33 articles:
HTML format



Single Articles


    March 2024
  1. SAVAS EM, Yegin ZA, Kok MI, Karayel HT, et al
    Hypomagnesemia May Predict Better Survival and Reduced Nonrelapse Mortality in Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Transplant Proc. 2024;56:386-393.
    PubMed     Abstract available


    February 2024
  2. LEE JH, Lee H, Kim K, Lee SW, et al
    High-Dose Intravenous Immunoglobulin to Treat Anti-Thymocyte Globulin Induction-Related BK Virus and Cytomegalovirus Infection in Patients with ABO-Incompatible Kidney Transplantation.
    Transplant Proc. 2024 Feb 21:S0041-1345(24)00028.
    PubMed     Abstract available


  3. KWON OK, Jeong ES, Lee KW, Choi MR, et al
    Monitoring Porcine Cytomegalovirus in Both Donors and Recipients is Crucial for Recipient's Survival in Pig-to-Cynomolgus Xenotransplantation.
    Transplant Proc. 2024 Feb 19:S0041-1345(24)00022.
    PubMed     Abstract available


  4. GRAF M, Tuly R, Pednekar P, Wang C, et al
    Gaining Consensus Around Patient Risk Groups and Prognostic Profiles to Guide CMV Management Among Patients With Allogeneic Hematopoietic Stem Cell Transplant: Insights From a Delphi Panel With Hematopoietic Stem Cell Transplant Experts.
    Transplant Proc. 2024 Feb 17:S0041-1345(24)00077.
    PubMed     Abstract available


  5. KLEIBOEKER H, Descourouez JL, Schulz LT, Mandelbrot DA, et al
    Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients.
    Transplant Proc. 2024 Feb 13:S0041-1345(24)00061.
    PubMed     Abstract available


  6. IDE K, Tanaka A, Tanaka Y, Nakano R, et al
    Anti-Donor T-Cell Responses Are Not Necessarily Attenuated During Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2024 Feb 7:S0041-1345(24)00050.
    PubMed     Abstract available


    January 2024
  7. FARKAS K, Varga M, Dinnyes I, Rem L, et al
    Low-Dose vs Standard-Dose Valganciclovir for Cytomegalovirus Prophylaxis After Kidney Transplantation: A Single-Center Retrospective Analysis.
    Transplant Proc. 2024 Jan 9:S0041-1345(23)00783.
    PubMed     Abstract available


  8. LO TY, Wang YL, Jaing TH, Chang TY, et al
    Early Allogeneic Transplantation Favorably Influences the Outcome of Pediatric Acute Myeloid Leukemia-A Retrospective Study in a Single Center Over 2 Decades.
    Transplant Proc. 2024;56:201-210.
    PubMed     Abstract available


    September 2023
  9. ROMAO EA, Yamamoto AY, Gaspar GG, Garcia TMP, et al
    Significant Increase in Cytomegalovirus (CMV) Infection in Solid Organ Transplants Associated With Increased Use of Thymoglobulin as Induction Therapy?
    Transplant Proc. 2023 Sep 29:S0041-1345(23)00564.
    PubMed     Abstract available


  10. SAHIN AZ, Ozdemir O, Usalan O, Erdur FM, et al
    Effects of Induction Therapy on Graft Functions in Terms of Immunologic Risk.
    Transplant Proc. 2023;55:1551-1554.
    PubMed     Abstract available


    July 2023
  11. SHIINA Y, Kawabe M, Suehiro Y, Katsumata H, et al
    Peripheral Blood Absolute Lymphocyte Count as a Predictor of Cytomegalovirus Infection in Kidney Transplant Recipients.
    Transplant Proc. 2023 Jul 7:S0041-1345(23)00398.
    PubMed     Abstract available


    April 2023
  12. TOYA K, Tomimaru Y, Kobayashi S, Ito T, et al
    Impact of Cytomegalovirus Infection and Disease on Graft Loss After Pancreas Transplantation: A Single-Institution Study in Japan.
    Transplant Proc. 2023 Apr 29:S0041-1345(23)00223.
    PubMed     Abstract available


  13. ISHIKAWA S, Tasaki M, Saito K, Nakagawa Y, et al
    Acquisition of Antibody Against Cytomegalovirus After Kidney Transplantation in Seronegative Recipients.
    Transplant Proc. 2023 Apr 13:S0041-1345(23)00126.
    PubMed     Abstract available


  14. TANAKA A, Ide K, Tanaka Y, Sasaki Y, et al
    Evaluation of T-Cell Immune Status of Reduced-Dose Cyclosporine and Everolimus Combination Therapy in Kidney Transplant Patients.
    Transplant Proc. 2023 Apr 8:S0041-1345(23)00138.
    PubMed     Abstract available


    February 2023
  15. CURRIER EE, Ichkanian Y, Dabaja M, Segovia MC, et al
    Cytomegalovirus Infection Management in Multivisceral and Intestinal Transplant: A Dual Institution Study.
    Transplant Proc. 2023 Feb 13:S0041-1345(23)00015.
    PubMed     Abstract available


    January 2023
  16. TOMIZAWA M, Hori S, Inoue K, Nishimura N, et al
    A Low Tacrolimus Concentration-to-Dose Ratio Increases Calcineurin Inhibitor Nephrotoxicity and Cytomegalovirus Infection Risks in Kidney Transplant Recipients: A Single-Center Study in Japan.
    Transplant Proc. 2023 Jan 7:S0041-1345(22)00881.
    PubMed     Abstract available


  17. HELLEMANS R, Bertels A, Wijtvliet V, Wouters K, et al
    Is Polyomavirus-Associated Nephropathy More Common in Kidney Transplant Recipients Exposed to Valganciclovir? A Retrospective Single Center Analysis.
    Transplant Proc. 2023 Jan 4:S0041-1345(22)00781.
    PubMed     Abstract available


    November 2022
  18. MATSUSHIMA H, Adachi T, Imamura H, Ono S, et al
    Cytomegalovirus Graft Duodenitis Diagnosed by Transanal Double-Balloon Endoscopy Technique in an Enteric-Drained Pancreas Transplant Recipient: A Case Report.
    Transplant Proc. 2022 Nov 18:S0041-1345(22)00699.
    PubMed     Abstract available


    July 2022
  19. IMAMURA H, Adachi T, Tanaka T, Matsushima H, et al
    Recurrent Cytomegalovirus Infection Controlled by the Introduction of Everolimus in a Simultaneous Pancreas-Kidney Transplantation Recipient: A Case Report.
    Transplant Proc. 2022 Jul 29. pii: S0041-1345(22)00401.
    PubMed     Abstract available


  20. JOHARJI H, Alaidaros F, Koujan H, Hamad A, et al
    A Case Report of Successful Use of Twice-Daily Letermovir in the Treatment of Resistant Cytomegalovirus in a Small Bowel Transplant Recipient.
    Transplant Proc. 2022 Jul 13. pii: S0041-1345(22)00399.
    PubMed     Abstract available


    June 2022
  21. JANICKA-MASZKE Z, Konopa J, Slizien M, Glasner P, et al
    Cytomegaloviral Retinitis in a Heart Transplant Patient: Case Report and Review of the Literature.
    Transplant Proc. 2022 Jun 24. pii: S0041-1345(22)00216.
    PubMed     Abstract available


    April 2022
  22. RODRIGUES AC, Fernandes S, Bustorff M, Nunes AT, et al
    Spleen-Restricted Posttransplant Lymphoproliferative Disorder in the First Year After Kidney Transplant - A Case Report.
    Transplant Proc. 2022 Apr 26. pii: S0041-1345(22)00263.
    PubMed     Abstract available


    September 2021
  23. REVUELTA-SALGADO F, Margallo-Iribarnegaray J, De Pablo-Gafas A, Alonso-Moralejo R, et al
    Influence of Cytomegalovirus on the Survival of Cytomegalovirus-Seropositive Lung Transplant.
    Transplant Proc. 2021 Sep 29. pii: S0041-1345(21)00631.
    PubMed     Abstract available


    August 2021
  24. JUN KW, Lim JH, Hwang JK, Park SC, et al
    Selection of More Vulnerable Patients for Cytomegalovirus Infection in Renal Transplant Recipients With Antithymocyte Globulin Induction Therapy: An Analysis of Risk Factors and Cell-Mediated Immunity.
    Transplant Proc. 2021 Aug 25. pii: S0041-1345(21)00499.
    PubMed     Abstract available


  25. NUANSRI S, Kantachuvesiri S, Watcharananan SP, Thongprayoon C, et al
    Clinical Characteristics of Late-Onset Cytomegalovirus Infection After Kidney Transplantation.
    Transplant Proc. 2021 Aug 14. pii: S0041-1345(21)00506.
    PubMed     Abstract available


    July 2021
  26. LEE JH, Lee H, Lee SW, Hwang SD, et al
    Efficacy and Safety According to the Dose of Valganciclovir for Cytomegalovirus Prophylaxis in Transplantation: Network Meta-analysis Using Recent Data.
    Transplant Proc. 2021 Jul 9. pii: S0041-1345(21)00418.
    PubMed     Abstract available


    May 2021
  27. HENNINGSEN M, Jaenigen B, Zschiedrich S, Pisarski P, et al
    Risk Factors and Management of Leukopenia After Kidney Transplantation: A Single-Center Experience.
    Transplant Proc. 2021 May 18. pii: S0041-1345(21)00258.
    PubMed     Abstract available


  28. ZAJAC-SPYCHALA O, Pieczonka A, Janura-Szymanska J, Jonczyk-Potoczna K, et al
    Multiple Reactivations of Viral Infections Followed by Cerebral Toxoplasmosis After Allogeneic Hematopoietic Stem Cell Transplantation in an Adolescent With Ph(+) Acute Lymphoblastic Leukemia: A Case Report.
    Transplant Proc. 2021;53:1355-1359.
    PubMed     Abstract available


    April 2021
  29. OOMEN L, de Wall LL, Cornelissen EAM, Feitz WFJ, et al
    Prognostic Factors on Graft Function in Pediatric Kidney Recipients.
    Transplant Proc. 2021;53:889-896.
    PubMed     Abstract available


    March 2021
  30. PEARSTON AP, Ingemi AI, Ripley K, Wilson TJ, et al
    Successful Treatment of UL97 Mutation Ganciclovir-Resistant Cytomegalovirus Viremia in a Renal Transplant Recipient With Letermovir and Adjunct Hyperimmune Cytomegalovirus Immunoglobulin: A Case Report.
    Transplant Proc. 2021 Mar 11. pii: S0041-1345(21)00112.
    PubMed     Abstract available


    September 2020
  31. HEENEY S, Szempruch KR, Lee RM, Mintz A, et al
    The Effect of Tacrolimus Trough Variability on Kidney Transplant Outcomes.
    Transplant Proc. 2020 Sep 4. pii: S0041-1345(20)32670.
    PubMed     Abstract available


    June 2020
  32. UENO T, Kodama T, Noguchi Y, Deguchi K, et al
    One Year of Preemptive Valganciclovir Administration in Children After Liver Transplantation.
    Transplant Proc. 2020 Jun 19. pii: S0041-1345(19)31851.
    PubMed     Abstract available


  33. ANGELICA AYRES RDC, Fonseca-Neto OCLD, Aquino RCA, Ribeiro KB, et al
    Use of Liver Grafts From Deceased Organ Donors With Infectious Diseases.
    Transplant Proc. 2020;52:1231-1235.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cytomegalovirus Infection is free of charge.